Increasing costs and decreased productivity have hampered growth and investment in the global life sciences and health-care sector. The open-innovation approach embraced by many industries could transform the way biotech and health-care companies innovate—bringing products and services to market quickly and efficiently.
What does this mean for business and consumers in Ontario?
Presenting diverse perspectives, this breakfast panel examines the open-innovation approach and identifies opportunities and challenges for health-care stakeholders as they position themselves in the value chain. Learn how to use this approach and leverage it with success.
John McCulloch, Senior Advisor, Life Sciences and Health Care, MaRS
Mark Lundie, Director of R&D, Pfizer Canada
Michael May, CEO, The Centre for Commercialization of Regenerative Medicine (CCRM)
Niall Wallace, CEO, Infonaut Inc.
Aled Edwards, Director and CEO, Structural Genomics Consortium